Literature DB >> 19785027

Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.

Margarita Raygada1, Diane C Arthur, Alan S Wayne, Owen M Rennert, Jeffrey A Toretsky, Constantine A Stratakis.   

Abstract

The association of neurofibromatosis 1 (NF1), juvenile xanthogranulomas (JXG), and juvenile myelomonocytic leukemia (JMML) has been previously reported. We describe herein this triad in a Caucasian male infant with a pathogenic mutation in the NF1 gene (neurofibromin). The clinical course from initial presentation to final diagnosis is detailed; the physical features and hematologic characteristics are discussed. The patient underwent bone marrow transplantation and is currently in remission. Children with concurrent cutaneous café-au-lait and JXG lesions should be evaluated and monitored closely for the possible development of JMML. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19785027      PMCID: PMC2783853          DOI: 10.1002/pbc.22297

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  JXG, NF1, and JMML: alphabet soup or a clinical issue?

Authors:  Walter H C Burgdorf; Bernhard Zelger
Journal:  Pediatr Dermatol       Date:  2004 Mar-Apr       Impact factor: 1.588

Review 2.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.

Authors:  Stefano Cambiaghi; Lucia Restano; Ruggero Caputo
Journal:  Pediatr Dermatol       Date:  2004 Mar-Apr       Impact factor: 1.588

4.  [Xantholeukemia in infants & Recklinghausen's neurofibromatosis].

Authors:  P ROYER; C BLONDET; J GUIHARD
Journal:  Sem Hop       Date:  1958-05-24

Review 5.  Treatment of juvenile xanthogranuloma.

Authors:  Daniel G Stover; Srilatha Alapati; Osvaldo Regueira; Curtis Turner; James A Whitlock
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

6.  Juvenile myelomonocytic leukemia: report of seven cases and review of literature.

Authors:  Latha Urs; Stephen J Qualman; Samir B Kahwash
Journal:  Pediatr Dev Pathol       Date:  2008-08-22

Review 7.  Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.

Authors:  A Zvulunov; Y Barak; A Metzker
Journal:  Arch Dermatol       Date:  1995-08

Review 8.  Neurofibromatosis.

Authors:  P A Gerber; A S Antal; N J Neumann; B Homey; C Matuschek; M Peiper; Wilfried Budach; E Bölke
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

9.  Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.

Authors:  C A Stiller; J M Chessells; M Fitchett
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  9 in total
  9 in total

1.  Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity.

Authors:  Christian N Paxton; Dennis P O'Malley; Andrew M Bellizzi; Deema Alkapalan; Yuri Fedoriw; Jason L Hornick; Sherrie L Perkins; Sarah T South; Erica F Andersen
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

Review 2.  Skin tumors in childhood.

Authors:  Henning Hamm; Peter H Höger
Journal:  Dtsch Arztebl Int       Date:  2011-05-20       Impact factor: 5.594

3.  Uncommon Presentation of a Common Histiocytic Tumor: A Rare Entity.

Authors:  Chinmay Kar; Kapildev Das; Jayanta K Barua
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

Review 4.  Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.

Authors:  Sherise D Ferguson; Steven G Waguespack; Lauren A Langford; Joann L Ater; Ian E McCutcheon
Journal:  Childs Nerv Syst       Date:  2014-12-12       Impact factor: 1.475

5.  Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.

Authors:  Mi-Ae Jang; Young-Eun Kim; Sun Kyung Kim; Myoung-Keun Lee; Jong-Won Kim; Chang-Seok Ki
Journal:  J Hum Genet       Date:  2016-04-14       Impact factor: 3.172

6.  Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.

Authors:  Harleen Chohan; Mitra Esfandiarei; Darian Arman; Catherine D Van Raamsdonk; Cornelis van Breemen; Jan M Friedman; Kimberly A Jett
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

7.  Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype.

Authors:  Filomena Napolitano; Milena Dell'Aquila; Chiara Terracciano; Giuseppina Franzese; Maria Teresa Gentile; Giulio Piluso; Claudia Santoro; Davide Colavito; Anna Patanè; Paolo De Blasiis; Simone Sampaolo; Simona Paladino; Mariarosa Anna Beatrice Melone
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

8.  Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma.

Authors:  Philipp Tschandl; Leonhard Müllauer; Harald Kittler
Journal:  Dermatol Pract Concept       Date:  2012-07-31

9.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.